InvestorsHub Logo
icon url

der246

05/26/14 12:10 PM

#19199 RE: haysaw #19195

1 Without a doubt it MUST significantly lower or suppress inflamation and in turn effectively treat the targeted disease more than the placebo to gain approval.

2 As to your 10,20 year comment it's past the ten year mark or pretty close. You can say that about 20 or 40 years from now on any drug. What happens if the disease is left untreated for 20 years? 50 million tablets have been taken virtually without problems. Future Harm?...It's in Tomatoes, Eggplant Onions, etc. How long have they been consumed?

3 As to dilution...Well we don't know what the financing is. Usually it's a teaming or partnership arrangement. If we get FDA approval the PPS goes viral. If not we are bankrupt. That's all I said and it's correct.

4 In terms of pharma fraud like at Merck and Pfizer...It happens. IMO Dr. Mullen is a respected SCIENTIST so are the 60 SCIENTISTS at Roskamp. Are they all Conspiring to commit a fraud? Are all the prestigious Universities in Europe embracing Dr. Mullen in NILVAD because he has a reputation for being sleezy?

On 3/20 Dr. Mullen and Dr Chapman set forth a timeline. Phase 2 begins early 2015... 6 short months from now. They would not say that if they didn't have funding. Either way I am long. Whatever you are...If you have a position in the stock good luck. We will know in 12 to 18 months if world renowned Dr. Mullen and the 60 Roskamp scientists with PHd degrees are competant.